Comentario editorial. Betabloqueantes y Covid-19
Leído
2642
Vecesse ha leído el artículo
946
Total PDF
1696
Total HTML
Información del artículo
ISSN: X7351097Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 13 | 13 | 26 |
| 2025 5 | 29 | 11 | 40 |
| 2025 4 | 14 | 8 | 22 |
| 2025 3 | 15 | 14 | 29 |
| 2025 2 | 8 | 11 | 19 |
| 2025 1 | 10 | 9 | 19 |
| 2024 12 | 17 | 9 | 26 |
| 2024 11 | 15 | 21 | 36 |
| 2024 10 | 7 | 13 | 20 |
| 2024 9 | 10 | 16 | 26 |
| 2024 8 | 8 | 13 | 21 |
| 2024 7 | 10 | 16 | 26 |
| 2024 6 | 18 | 17 | 35 |
| 2024 5 | 30 | 8 | 38 |
| 2024 4 | 14 | 17 | 31 |
| 2024 3 | 21 | 16 | 37 |
| 2024 2 | 9 | 13 | 22 |
| 2024 1 | 17 | 25 | 42 |
| 2023 12 | 10 | 32 | 42 |
| 2023 11 | 14 | 31 | 45 |
| 2023 10 | 14 | 43 | 57 |
| 2023 9 | 20 | 35 | 55 |
| 2023 8 | 12 | 2 | 14 |
| 2023 7 | 8 | 10 | 18 |
| 2023 6 | 13 | 15 | 28 |
| 2023 5 | 12 | 10 | 22 |
| 2023 4 | 11 | 18 | 29 |
| 2023 3 | 45 | 35 | 80 |
| 2023 2 | 96 | 28 | 124 |
| 2022 1 | 94 | 31 | 125 |
| 2022 12 | 125 | 30 | 155 |
| 2022 11 | 532 | 33 | 565 |
| 2022 10 | 84 | 54 | 138 |
| 2022 9 | 60 | 53 | 113 |
| 2022 8 | 60 | 32 | 92 |
| 2022 7 | 59 | 38 | 97 |
| 2022 6 | 42 | 30 | 72 |
| 2022 5 | 31 | 22 | 53 |
| 2022 4 | 37 | 46 | 83 |
| 2022 3 | 32 | 42 | 74 |
| 2022 2 | 20 | 26 | 46 |
Mostrar todo
